In the last 12 months, insiders at EyePoint, Inc. ($EYPT) filed 353 transactions with the SEC: 15 open-market purchases totaling $37,939,941 and 36 sales totaling $81,442,216. Net insider sentiment: net selling.
EyePoint, Inc. operates in the Laboratory analytical instruments industry (Industrial Applications and Services sector).
Most Active Insiders
- Cormorant Asset Management, LP (Not found) — 7 transactions totaling $38,564,507
- Liu Ye (Not found) — 1 transaction totaling $37,159,225
- Ocumension Therapeutics (Director) — 1 transaction totaling $37,159,225
- Duker Jay S. (President and CEO) — 52 transactions totaling $3,992,077
- Paggiarino Dario A. (Chief Medical Officer) — 50 transactions totaling $3,880,346
View all SEC Filings for EyePoint, Inc. (EYPT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Duker Jay S. | President and CEO | J | Stock Option (Right to Buy) | 97500 | $9.57 | 180,000.0000 | 82,787,220 | 118.18% | 0.12% |
| March 23, 2026 | Duker Jay S. | President and CEO | J | Common Stock | 76766 | $13.11 | 178,417.0000 | 82,787,220 | 75.52% | 0.09% |
| March 23, 2026 | Duker Jay S. | President and CEO | J | Common Stock | 76766 | $13.11 | 178,417.0000 | 82,787,220 | 30.08% | 0.09% |
| March 23, 2026 | Duker Jay S. | President and CEO | J | Stock Option (Right to Buy) | 52500 | $8.75 | 105,300.0000 | 82,787,220 | 33.27% | 0.06% |
| March 23, 2026 | Duker Jay S. | President and CEO | J | Stock Option (Right to Buy) | 52500 | $8.75 | 135,000.0000 | 82,787,220 | 63.64% | 0.06% |
| March 23, 2026 | Duker Jay S. | President and CEO | J | Stock Option (Right to Buy) | 97500 | $9.57 | 180,000.0000 | 82,787,220 | 35.14% | 0.12% |
| March 16, 2026 | Duker Jay S. | President and CEO | P | Common Stock | 1500 | $13.15 | 178,417.0000 | 82,787,220 | 0.85% | 0.00% |
| March 2, 2026 | Elston George | Chief Financial Officer | G | Common Stock | 5000 | $0.00 | 117,818.0000 | 82,787,220 | 4.43% | 0.01% |
| March 2, 2026 | Elston George | Chief Financial Officer | G | Common Stock | 5000 | $0.00 | 117,818.0000 | 82,787,220 | 4.07% | 0.01% |
| March 4, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Common Stock | 2438 | $8.26 | 2,438.0000 | 82,787,220 | 9999.99% | 0.00% |
| March 4, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Stock Option (Right to Buy) | 2438 | $0.00 | 82,875.0000 | 82,787,220 | 2.86% | 0.00% |
| March 4, 2026 | Ribeiro Ramiro | Chief Medical Officer | S | Common Stock | 2438 | $17.87 | 0.0000 | 82,787,220 | 100.00% | 0.00% |
| Feb. 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Stock Option (Right to Buy) | 2437 | $0.00 | 85,313.0000 | 82,787,220 | 2.78% | 0.00% |
| Feb. 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | S | Common Stock | 2437 | $15.00 | 0.0000 | 82,787,220 | 100.00% | 0.00% |
| Feb. 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Common Stock | 2437 | $8.26 | 2,437.0000 | 82,787,220 | 9999.99% | 0.00% |
| Jan. 6, 2026 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 15285 | $0.00 | 0.0000 | 82,787,220 | 100.00% | 0.02% |
| Jan. 6, 2026 | Elston George | Chief Financial Officer | F | Common Stock | 4487 | $16.86 | 116,852.0000 | 82,787,220 | 3.70% | 0.01% |
| Jan. 6, 2026 | Elston George | Chief Financial Officer | M | Common Stock | 15285 | $0.00 | 121,339.0000 | 82,787,220 | 14.41% | 0.02% |
| Jan. 6, 2026 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 20793 | $0.00 | 0.0000 | 82,787,220 | 100.00% | 0.03% |
| Jan. 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Stock Option (Right to Buy) | 29250 | $0.00 | 87,750.0000 | 82,787,220 | 25.00% | 0.04% |
| Jan. 6, 2026 | Duker Jay S. | President and CEO | M | Common Stock | 20793 | $0.00 | 186,971.0000 | 82,787,220 | 12.51% | 0.03% |
| Jan. 6, 2026 | Lurker Nancy | Not found | M | Common Stock | 75133 | $0.00 | 421,235.0000 | 82,787,220 | 21.71% | 0.09% |
| Jan. 6, 2026 | Lurker Nancy | Not found | M | Restricted Stock Units | 75133 | $0.00 | 0.0000 | 82,787,220 | 100.00% | 0.09% |
| Jan. 6, 2026 | Duker Jay S. | President and CEO | F | Common Stock | 10054 | $16.86 | 176,917.0000 | 82,787,220 | 5.38% | 0.01% |
| Jan. 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | S | Common Stock | 42544 | $17.10 | 0.0000 | 82,787,220 | 100.00% | 0.05% |
| Jan. 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Common Stock | 29250 | $8.26 | 42,544.0000 | 82,787,220 | 220.02% | 0.04% |
| Jan. 2, 2026 | Zaderej Karen L. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 3, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Common Stock | 19667 | $0.00 | 19,667.0000 | 82,787,220 | 9999.99% | 0.02% |
| Jan. 3, 2026 | Ribeiro Ramiro | Chief Medical Officer | F | Common Stock | 6373 | $17.48 | 13,294.0000 | 82,787,220 | 32.40% | 0.01% |
| Jan. 2, 2026 | Ribeiro Ramiro | Chief Medical Officer | A | Restricted Stock Units | 85700 | $0.00 | 85,700.0000 | 82,787,220 | 9999.99% | 0.10% |
| Jan. 2, 2026 | Ribeiro Ramiro | Chief Medical Officer | A | Stock Option (Right to Buy) | 171400 | $0.00 | 171,400.0000 | 82,787,220 | 9999.99% | 0.21% |
| Jan. 3, 2026 | Ribeiro Ramiro | Chief Medical Officer | M | Restricted Stock Units | 19667 | $0.00 | 39,333.0000 | 82,787,220 | 33.33% | 0.02% |
| Jan. 3, 2026 | Duker Jay S. | President and CEO | M | Common Stock | 65000 | $0.00 | 174,130.0000 | 82,787,220 | 59.56% | 0.08% |
| Jan. 3, 2026 | Duker Jay S. | President and CEO | F | Common Stock | 23447 | $17.48 | 150,683.0000 | 82,787,220 | 13.47% | 0.03% |
| Jan. 5, 2026 | Duker Jay S. | President and CEO | M | Common Stock | 30000 | $0.00 | 180,683.0000 | 82,787,220 | 19.91% | 0.04% |
| Jan. 5, 2026 | Duker Jay S. | President and CEO | F | Common Stock | 14505 | $17.43 | 166,178.0000 | 82,787,220 | 8.03% | 0.02% |
| Jan. 2, 2026 | Duker Jay S. | President and CEO | A | Restricted Stock Units | 165000 | $0.00 | 165,000.0000 | 82,787,220 | 9999.99% | 0.20% |
| Jan. 2, 2026 | Duker Jay S. | President and CEO | A | Stock Option (Right to Buy) | 331000 | $0.00 | 331,000.0000 | 82,787,220 | 9999.99% | 0.40% |
| Jan. 3, 2026 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 65000 | $0.00 | 130,000.0000 | 82,787,220 | 33.33% | 0.08% |
| Jan. 5, 2026 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 82,787,220 | 50.00% | 0.04% |
| Jan. 3, 2026 | Elston George | Chief Financial Officer | M | Common Stock | 19667 | $0.00 | 101,781.0000 | 82,787,220 | 23.95% | 0.02% |
| Jan. 3, 2026 | Elston George | Chief Financial Officer | F | Common Stock | 6324 | $17.48 | 95,457.0000 | 82,787,220 | 6.21% | 0.01% |
| Jan. 5, 2026 | Elston George | Chief Financial Officer | M | Common Stock | 15000 | $0.00 | 110,457.0000 | 82,787,220 | 15.71% | 0.02% |
| Jan. 5, 2026 | Elston George | Chief Financial Officer | F | Common Stock | 4403 | $17.43 | 106,054.0000 | 82,787,220 | 3.99% | 0.01% |
| Jan. 2, 2026 | Elston George | Chief Financial Officer | A | Restricted Stock Units | 63000 | $0.00 | 63,000.0000 | 82,787,220 | 9999.99% | 0.08% |
| Jan. 2, 2026 | Elston George | Chief Financial Officer | A | Stock Option (Right to Buy) | 126000 | $0.00 | 126,000.0000 | 82,787,220 | 9999.99% | 0.15% |
| Jan. 3, 2026 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 19667 | $0.00 | 39,333.0000 | 82,787,220 | 33.33% | 0.02% |
| Jan. 5, 2026 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 82,787,220 | 50.00% | 0.02% |
| Jan. 2, 2026 | Sanders Reginald J. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 5, 2026 | Lurker Nancy | Not found | M | Common Stock | 12666 | $0.00 | 346,102.0000 | 82,787,220 | 3.80% | 0.02% |
| Jan. 2, 2026 | Lurker Nancy | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 5, 2026 | Lurker Nancy | Not found | M | Restricted Stock Units | 12666 | $0.00 | 12,667.0000 | 82,787,220 | 50.00% | 0.02% |
| Jan. 2, 2026 | Landis John B. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Duty Stuart | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Hassan Fred | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 2, 2026 | DICICCO WENDY F | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 2, 2026 | ANDO GORAN | Not found | A | Stock Option (Right to Buy) | 41500 | $0.00 | 41,500.0000 | 82,787,220 | 9999.99% | 0.05% |
| Dec. 19, 2025 | Elston George | Chief Financial Officer | G | Common Stock | 5000 | $0.00 | 82,114.0000 | 82,787,220 | 6.48% | 0.01% |
| Dec. 19, 2025 | Elston George | Chief Financial Officer | G | Common Stock | 5000 | $0.00 | 82,114.0000 | 82,787,220 | 5.74% | 0.01% |
| Dec. 4, 2025 | Cormorant Asset Management, LP | Not found | S | Common Stock | 60000 | $15.70 | 8,265,000.0000 | 82,787,220 | 0.72% | 0.07% |
| Dec. 4, 2025 | Lurker Nancy | Not found | S | Common Stock | 9300 | $15.11 | 333,436.0000 | 82,787,220 | 2.71% | 0.01% |
| Nov. 28, 2025 | Lurker Nancy | Not found | S | Common Stock | 500 | $14.95 | 342,736.0000 | 82,787,220 | 0.15% | 0.00% |
| Nov. 26, 2025 | Lurker Nancy | Not found | S | Common Stock | 200 | $14.95 | 343,236.0000 | 82,787,220 | 0.06% | 0.00% |
| Nov. 11, 2025 | Ribeiro Ramiro | Chief Medical Officer | S | Common Stock | 2722 | $11.61 | 0.0000 | 82,787,220 | 100.00% | 0.00% |
| Sept. 19, 2025 | Elston George | Chief Financial Officer | G | Common Stock | 20000 | $0.00 | 82,114.0000 | 68,728,760 | 32.20% | 0.03% |
| Sept. 19, 2025 | Elston George | Chief Financial Officer | G | Common Stock | 20000 | $0.00 | 82,114.0000 | 68,728,760 | 19.59% | 0.03% |
| July 11, 2025 | Zaderej Karen L. | Not found | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 68,728,760 | 100.00% | 0.00% |
| July 10, 2025 | Lurker Nancy | Not found | M | Common Stock | 11111 | $0.00 | 343,436.0000 | 68,728,760 | 3.34% | 0.02% |
| July 10, 2025 | Lurker Nancy | Not found | M | Restricted Stock Units | 11111 | $0.00 | 11,112.0000 | 68,728,760 | 50.00% | 0.02% |
| July 10, 2025 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 16667 | $0.00 | 16,667.0000 | 68,728,760 | 50.00% | 0.02% |
| July 10, 2025 | Duker Jay S. | President and CEO | F | Common Stock | 7688 | $11.06 | 109,130.0000 | 68,728,760 | 6.58% | 0.01% |
| July 10, 2025 | Duker Jay S. | President and CEO | M | Common Stock | 16667 | $0.00 | 116,818.0000 | 68,728,760 | 16.64% | 0.02% |
| July 11, 2025 | Zaderej Karen L. | Not found | M | Common Stock | 2000 | $0.00 | 38,500.0000 | 68,728,760 | 5.48% | 0.00% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 31165 | $0.00 | 27,270.0000 | 68,728,760 | 53.33% | 0.05% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 31165 | $0.00 | 263,430.0000 | 68,728,760 | 13.42% | 0.05% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 55000 | $0.00 | 67,270.0000 | 68,728,760 | 44.98% | 0.08% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 27270 | $0.00 | 77,000.0000 | 68,728,760 | 54.84% | 0.04% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 27270 | $0.00 | 77,000.0000 | 68,728,760 | 26.15% | 0.04% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 15278 | $0.00 | 81,674.0000 | 68,728,760 | 23.01% | 0.02% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 15278 | $0.00 | 61,992.0000 | 68,728,760 | 19.77% | 0.02% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 103308 | $0.00 | 322,088.0000 | 68,728,760 | 47.22% | 0.15% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 103308 | $0.00 | 205,712.0000 | 68,728,760 | 33.43% | 0.15% |
| July 2, 2025 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 55000 | $0.00 | 249,730.0000 | 68,728,760 | 28.24% | 0.08% |
| June 23, 2025 | Duker Jay S. | President and CEO | J | Common Stock | 56665 | $8.21 | 100,151.0000 | 68,728,760 | 36.13% | 0.08% |
| May 25, 2025 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 7500 | $0.00 | 7,500.0000 | 68,728,760 | 50.00% | 0.01% |
| May 25, 2025 | Elston George | Chief Financial Officer | M | Common Stock | 7500 | $0.00 | 83,050.0000 | 68,728,760 | 9.93% | 0.01% |
| May 25, 2025 | Elston George | Chief Financial Officer | F | Common Stock | 2202 | $5.68 | 80,848.0000 | 68,728,760 | 2.65% | 0.00% |
| May 16, 2025 | Zaderej Karen L. | Not found | P | Common Stock | 5000 | $5.81 | 31,500.0000 | 68,728,760 | 18.87% | 0.01% |
| May 19, 2025 | Zaderej Karen L. | Not found | P | Common Stock | 5000 | $5.99 | 36,500.0000 | 68,728,760 | 15.87% | 0.01% |
| May 14, 2025 | Zaderej Karen L. | Not found | P | Common Stock | 5000 | $5.42 | 21,500.0000 | 68,728,760 | 30.30% | 0.01% |
| May 15, 2025 | Zaderej Karen L. | Not found | P | Common Stock | 5000 | $5.47 | 26,500.0000 | 68,728,760 | 23.26% | 0.01% |
| March 19, 2025 | Duker Jay S. | President and CEO | J | Common Stock | 20000 | $6.16 | 100,151.0000 | 68,728,760 | 16.65% | 0.03% |
| Feb. 9, 2025 | Lurker Nancy | Not found | M | Restricted Stock Units | 20000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2025 | Elston George | Chief Financial Officer | M | Common Stock | 5834 | $0.00 | 75,550.0000 | 0 | 8.37% | 0.00% |
| Feb. 9, 2025 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 5834 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2025 | Lurker Nancy | Not found | M | Common Stock | 20000 | $0.00 | 332,325.0000 | 0 | 6.40% | 0.00% |
| Feb. 9, 2025 | Duker Jay S. | President and CEO | M | Common Stock | 7000 | $0.00 | 102,206.0000 | 0 | 7.35% | 0.00% |
| Feb. 9, 2025 | Duker Jay S. | President and CEO | F | Common Stock | 2055 | $6.50 | 100,151.0000 | 0 | 2.01% | 0.00% |
| Feb. 9, 2025 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 7000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 8, 2025 | Sanders Reginald J. | Not found | A | Stock Options (Right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 15000 | $0.00 | 30,000.0000 | 0 | 33.33% | 0.00% |
| Jan. 6, 2025 | Elston George | Chief Financial Officer | M | Common Stock | 15285 | $0.00 | 73,374.0000 | 0 | 26.31% | 0.00% |
| Jan. 6, 2025 | Elston George | Chief Financial Officer | F | Common Stock | 4808 | $8.68 | 68,566.0000 | 0 | 6.55% | 0.00% |
| Jan. 3, 2025 | Elston George | Chief Financial Officer | A | Restricted Stock Units | 59000 | $0.00 | 74,000.0000 | 0 | 393.33% | 0.00% |
| Jan. 3, 2025 | Elston George | Chief Financial Officer | A | Stock Option (Right to Buy) | 117000 | $0.00 | 117,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 15285 | $0.00 | 14,715.0000 | 0 | 50.95% | 0.00% |
| Jan. 6, 2025 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 20794 | $0.00 | 39,206.0000 | 0 | 34.66% | 0.00% |
| Jan. 5, 2025 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 30000 | $0.00 | 60,000.0000 | 0 | 33.33% | 0.00% |
| Jan. 3, 2025 | Duker Jay S. | President and CEO | A | Stock Option (Right to Buy) | 390000 | $0.00 | 390,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Duker Jay S. | President and CEO | A | Restricted Stock Units | 195000 | $0.00 | 228,334.0000 | 0 | 584.99% | 0.00% |
| Jan. 6, 2025 | Duker Jay S. | President and CEO | F | Common Stock | 6108 | $8.68 | 95,206.0000 | 0 | 6.03% | 0.00% |
| Jan. 6, 2025 | Duker Jay S. | President and CEO | M | Common Stock | 20794 | $0.00 | 101,314.0000 | 0 | 25.82% | 0.00% |
| Jan. 5, 2025 | Duker Jay S. | President and CEO | F | Common Stock | 10007 | $8.26 | 80,520.0000 | 0 | 11.05% | 0.00% |
| Jan. 5, 2025 | Duker Jay S. | President and CEO | M | Common Stock | 30000 | $0.00 | 90,527.0000 | 0 | 49.56% | 0.00% |
| Jan. 5, 2025 | Landis John B. | Not found | M | Restricted Stock Units | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 3, 2025 | Landis John B. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Landis John B. | Not found | M | Common Stock | 10000 | $0.00 | 21,400.0000 | 0 | 87.72% | 0.00% |
| Jan. 6, 2025 | Lurker Nancy | Not found | M | Restricted Stock Units | 75134 | $0.00 | 75,133.0000 | 0 | 50.00% | 0.00% |
| Jan. 5, 2025 | Lurker Nancy | Not found | M | Restricted Stock Units | 12667 | $0.00 | 25,333.0000 | 0 | 33.33% | 0.00% |
| Jan. 3, 2025 | Lurker Nancy | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Lurker Nancy | Not found | M | Common Stock | 75134 | $0.00 | 312,325.0000 | 0 | 31.68% | 0.00% |
| Jan. 5, 2025 | Lurker Nancy | Not found | M | Common Stock | 12667 | $0.00 | 237,191.0000 | 0 | 5.64% | 0.00% |
| Jan. 3, 2025 | Hassan Fred | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Zaderej Karen L. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | ANDO GORAN | Not found | A | Stock Option (Right to Buy) | 41500 | $0.00 | 41,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Duty Stuart | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | DICICCO WENDY F | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Ribeiro Ramiro | Chief Medical Officer | A | Restricted Stock Units | 59000 | $0.00 | 59,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Ribeiro Ramiro | Chief Medical Officer | A | Stock Option (Right to Buy) | 117000 | $0.00 | 117,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Elston George | Chief Financial Officer | M | Common Stock | 15000 | $0.00 | 63,356.0000 | 0 | 31.02% | 0.00% |
| Jan. 5, 2025 | Elston George | Chief Financial Officer | F | Common Stock | 5267 | $8.26 | 58,089.0000 | 0 | 8.31% | 0.00% |
| Sept. 3, 2024 | Hassan Fred | Not found | A | Stock Options (Right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 19, 2024 | Zaderej Karen L. | Not found | P | Common Stock | 12500 | $7.98 | 16,500.0000 | 0 | 312.50% | 0.00% |
| Aug. 21, 2024 | ANDO GORAN | Not found | P | Common Stock | 5000 | $7.95 | 13,150.0000 | 0 | 61.35% | 0.00% |
| Aug. 20, 2024 | DICICCO WENDY F | Not found | P | Common Stock | 2567 | $7.79 | 9,967.0000 | 0 | 34.69% | 0.00% |
| Aug. 16, 2024 | Lurker Nancy | Not found | P | Common Stock | 3173 | $7.88 | 224,524.0000 | 0 | 1.43% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 1558 | $0.00 | 16,666.0000 | 0 | 8.55% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 1558 | $0.00 | 124,800.0000 | 0 | 1.26% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 26713 | $0.00 | 47,831.0000 | 0 | 35.84% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 26713 | $0.00 | 232,535.0000 | 0 | 12.98% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 30000 | $0.00 | 111,666.0000 | 0 | 21.18% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 30000 | $0.00 | 195,000.0000 | 0 | 18.18% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 56350 | $0.00 | 298,416.0000 | 0 | 15.88% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 56350 | $0.00 | 219,050.0000 | 0 | 34.63% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 16666 | $0.00 | 66,666.0000 | 0 | 20.00% | 0.00% |
| July 26, 2024 | Lurker Nancy | Not found | G | Stock Option (Right to Buy) | 16666 | $0.00 | 66,666.0000 | 0 | 33.33% | 0.00% |
| July 12, 2024 | GUYER DAVID R | Not found | M | Stock Option (Right to Buy) | 3250 | $0.00 | 3,250.0000 | 0 | 50.00% | 0.00% |
| July 12, 2024 | GUYER DAVID R | Not found | M | Stock Option (Right to Buy) | 6525 | $0.00 | 6,525.0000 | 0 | 50.00% | 0.00% |
| July 12, 2024 | GUYER DAVID R | Not found | S | Common Stock | 11625 | $10.06 | 1,850.0000 | 0 | 86.27% | 0.00% |
| July 12, 2024 | GUYER DAVID R | Not found | M | Common Stock | 6525 | $3.26 | 13,475.0000 | 0 | 93.88% | 0.00% |
| July 12, 2024 | GUYER DAVID R | Not found | M | Common Stock | 3250 | $3.50 | 6,950.0000 | 0 | 87.84% | 0.00% |
| July 11, 2024 | Zaderej Karen L. | Not found | M | Restricted Stock Units | 2000 | $0.00 | 2,000.0000 | 0 | 50.00% | 0.00% |
| July 10, 2024 | Duker Jay S. | President and CEO | F | Common Stock | 8059 | $8.69 | 60,527.0000 | 0 | 11.75% | 0.00% |
| July 10, 2024 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 16666 | $0.00 | 33,334.0000 | 0 | 33.33% | 0.00% |
| July 10, 2024 | Lurker Nancy | Executive Vice Chair | M | Common Stock | 11111 | $0.00 | 221,351.0000 | 0 | 5.28% | 0.00% |
| July 10, 2024 | Lurker Nancy | Executive Vice Chair | M | Restricted Stock Units | 11111 | $0.00 | 22,223.0000 | 0 | 33.33% | 0.00% |
| July 11, 2024 | Zaderej Karen L. | Not found | M | Common Stock | 2000 | $0.00 | 4,000.0000 | 0 | 100.00% | 0.00% |
| July 10, 2024 | Duker Jay S. | President and CEO | M | Common Stock | 16666 | $0.00 | 68,586.0000 | 0 | 32.10% | 0.00% |
| June 23, 2024 | ADAMIS ANTHONY P | Not found | M | Common Stock | 2000 | $0.00 | 4,000.0000 | 0 | 100.00% | 0.00% |
| June 23, 2024 | ADAMIS ANTHONY P | Not found | M | Restricted Stock Units | 2000 | $0.00 | 2,000.0000 | 0 | 50.00% | 0.00% |
| June 3, 2024 | GUYER DAVID R | Not found | M | Common Stock | 3250 | $3.50 | 15,325.0000 | 0 | 26.92% | 0.00% |
| June 3, 2024 | GUYER DAVID R | Not found | S | Common Stock | 11625 | $10.30 | 3,700.0000 | 0 | 75.86% | 0.00% |
| June 3, 2024 | GUYER DAVID R | Not found | M | Stock Option (Right to Buy) | 3250 | $0.00 | 6,500.0000 | 0 | 33.33% | 0.00% |
| June 3, 2024 | GUYER DAVID R | Not found | M | Stock Option (Right to Buy) | 6525 | $0.00 | 13,050.0000 | 0 | 33.33% | 0.00% |
| June 3, 2024 | GUYER DAVID R | Not found | M | Common Stock | 6525 | $3.26 | 12,075.0000 | 0 | 117.57% | 0.00% |
| May 25, 2024 | Elston George | Chief Financial Officer | M | Common Stock | 7500 | $0.00 | 51,107.0000 | 0 | 17.20% | 0.00% |
| May 25, 2024 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 7500 | $0.00 | 15,000.0000 | 0 | 33.33% | 0.00% |
| May 25, 2024 | Elston George | Chief Financial Officer | F | Common Stock | 3627 | $11.16 | 47,480.0000 | 0 | 7.10% | 0.00% |
| May 14, 2024 | GUYER DAVID R | Not found | M | Common Stock | 6525 | $3.26 | 13,925.0000 | 0 | 88.18% | 0.00% |
| May 14, 2024 | GUYER DAVID R | Not found | M | Stock Option (Right to Buy) | 3250 | $0.00 | 9,750.0000 | 0 | 25.00% | 0.00% |
| May 14, 2024 | GUYER DAVID R | Not found | S | Common Stock | 11625 | $12.65 | 5,550.0000 | 0 | 67.69% | 0.00% |
| May 14, 2024 | GUYER DAVID R | Not found | M | Common Stock | 3250 | $3.50 | 17,175.0000 | 0 | 23.34% | 0.00% |
| May 14, 2024 | GUYER DAVID R | Not found | M | Stock Option (Right to Buy) | 6525 | $0.00 | 19,575.0000 | 0 | 25.00% | 0.00% |
| May 6, 2024 | Cormorant Asset Management, LP | Not found | P | Common Stock | 207153 | $12.36 | 8,325,000.0000 | 0 | 2.55% | 0.00% |
| May 6, 2024 | Cormorant Asset Management, LP | Not found | P | Common Stock | 642847 | $11.70 | 8,117,847.0000 | 0 | 8.60% | 0.00% |
| April 18, 2024 | Cormorant Asset Management, LP | Not found | P | Common Stock | 395244 | $17.62 | 7,288,479.0000 | 0 | 5.73% | 0.00% |
| April 18, 2024 | Cormorant Asset Management, LP | Not found | P | Common Stock | 186521 | $18.90 | 7,475,000.0000 | 0 | 2.56% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | F | Common Stock | 2957 | $20.67 | 74,176.0000 | 0 | 3.83% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 5834 | $0.00 | 48,056.0000 | 0 | 13.82% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 30570 | $0.00 | 78,626.0000 | 0 | 63.61% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 14000 | $0.00 | 92,626.0000 | 0 | 17.81% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | F | Common Stock | 15493 | $20.67 | 77,133.0000 | 0 | 16.73% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | F | Common Stock | 7096 | $20.67 | 67,080.0000 | 0 | 9.57% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Restricted Stock Units | 30570 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Restricted Stock Units | 5834 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Restricted Stock Units | 14000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 1, 2024 | Ribeiro Ramiro | Chief Medical Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Duker Jay S. | President and CEO | G | Common Stock | 2500 | $0.00 | 51,920.0000 | 0 | 4.59% | 0.00% |
| Feb. 27, 2024 | Duker Jay S. | President and CEO | G | Common Stock | 2500 | $0.00 | 51,920.0000 | 0 | 5.06% | 0.00% |
| Feb. 20, 2024 | Duker Jay S. | President and CEO | G | Common Stock | 20000 | $0.00 | 51,920.0000 | 0 | 62.66% | 0.00% |
| Feb. 20, 2024 | Duker Jay S. | President and CEO | G | Common Stock | 20000 | $0.00 | 51,920.0000 | 0 | 27.81% | 0.00% |
| Feb. 9, 2024 | Lurker Nancy | Executive Vice Chair | M | Common Stock | 17534 | $0.00 | 299,864.0000 | 0 | 6.21% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 5000 | $0.00 | 240,000.0000 | 0 | 2.04% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 4452 | $0.00 | 280,822.0000 | 0 | 1.61% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 4452 | $0.00 | 172,878.0000 | 0 | 2.51% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 3116 | $0.00 | 198,242.0000 | 0 | 1.60% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 3116 | $0.00 | 116,558.0000 | 0 | 2.60% | 0.00% |
| Feb. 9, 2024 | Lurker Nancy | Executive Vice Chair | M | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 0 | 50.00% | 0.00% |
| Feb. 9, 2024 | Lurker Nancy | Executive Vice Chair | M | Restricted Stock Units | 17534 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Common Stock | 74681 | $0.00 | 210,240.0000 | 0 | 55.09% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Common Stock | 74681 | $0.00 | 210,240.0000 | 0 | 26.21% | 0.00% |
| Feb. 9, 2024 | Lurker Nancy | Executive Vice Chair | F | Common Stock | 6981 | $28.80 | 284,921.0000 | 0 | 2.39% | 0.00% |
| Feb. 9, 2024 | Lurker Nancy | Executive Vice Chair | F | Common Stock | 7962 | $28.80 | 291,902.0000 | 0 | 2.66% | 0.00% |
| Feb. 9, 2024 | Lurker Nancy | Executive Vice Chair | M | Common Stock | 20000 | $0.00 | 282,330.0000 | 0 | 7.62% | 0.00% |
| Feb. 9, 2024 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 7000 | $0.00 | 7,000.0000 | 0 | 50.00% | 0.00% |
| Feb. 9, 2024 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 4967 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Duker Jay S. | President and CEO | F | Common Stock | 1458 | $28.80 | 51,920.0000 | 0 | 2.73% | 0.00% |
| Feb. 9, 2024 | Duker Jay S. | President and CEO | F | Common Stock | 2075 | $28.80 | 53,378.0000 | 0 | 3.74% | 0.00% |
| Feb. 9, 2024 | Duker Jay S. | President and CEO | M | Common Stock | 4967 | $0.00 | 55,453.0000 | 0 | 9.84% | 0.00% |
| Feb. 9, 2024 | Duker Jay S. | President and CEO | M | Common Stock | 7000 | $0.00 | 50,486.0000 | 0 | 16.10% | 0.00% |
| Feb. 9, 2024 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 5833 | $0.00 | 5,834.0000 | 0 | 50.00% | 0.00% |
| Feb. 9, 2024 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 4967 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Elston George | Chief Financial Officer | F | Common Stock | 1458 | $28.80 | 43,607.0000 | 0 | 3.24% | 0.00% |
| Feb. 9, 2024 | Elston George | Chief Financial Officer | F | Common Stock | 1734 | $28.80 | 45,065.0000 | 0 | 3.71% | 0.00% |
| Feb. 9, 2024 | Elston George | Chief Financial Officer | M | Common Stock | 5833 | $0.00 | 46,799.0000 | 0 | 14.24% | 0.00% |
| Feb. 9, 2024 | Elston George | Chief Financial Officer | M | Common Stock | 4967 | $0.00 | 40,966.0000 | 0 | 13.80% | 0.00% |
| Feb. 9, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Restricted Stock Units | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Feb. 9, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Restricted Stock Units | 4967 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Jones David Scott | SVP & Chief Commercial Officer | F | Common Stock | 1701 | $28.80 | 44,916.0000 | 0 | 3.65% | 0.00% |
| Feb. 9, 2024 | Jones David Scott | SVP & Chief Commercial Officer | F | Common Stock | 1955 | $28.80 | 46,617.0000 | 0 | 4.02% | 0.00% |
| Feb. 9, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 48,572.0000 | 0 | 11.48% | 0.00% |
| Feb. 9, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 4967 | $0.00 | 43,572.0000 | 0 | 12.87% | 0.00% |
| Feb. 9, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Restricted Stock Units | 5833 | $0.00 | 5,834.0000 | 0 | 50.00% | 0.00% |
| Feb. 9, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Restricted Stock Units | 4967 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | Paggiarino Dario A. | Chief Medical Officer | F | Common Stock | 2565 | $28.80 | 42,222.0000 | 0 | 5.73% | 0.00% |
| Feb. 9, 2024 | Paggiarino Dario A. | Chief Medical Officer | F | Common Stock | 2518 | $28.80 | 44,787.0000 | 0 | 5.32% | 0.00% |
| Feb. 9, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 5833 | $0.00 | 47,305.0000 | 0 | 14.06% | 0.00% |
| Feb. 9, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 4967 | $0.00 | 41,472.0000 | 0 | 13.61% | 0.00% |
| Feb. 13, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 5000 | $0.00 | 240,000.0000 | 0 | 2.13% | 0.00% |
| Feb. 2, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 209 | $0.00 | 4,375.0000 | 0 | 4.56% | 0.00% |
| Feb. 2, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 209 | $28.49 | 37,962.0000 | 0 | 0.55% | 0.00% |
| Feb. 2, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 209 | $11.47 | 38,171.0000 | 0 | 0.55% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 15609 | $0.00 | 1,026.0000 | 0 | 93.83% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 33665 | $0.00 | 17,588.0000 | 0 | 65.68% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 51 | $25.41 | 85,779.0000 | 0 | 0.06% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 15609 | $25.41 | 70,170.0000 | 0 | 18.20% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 33665 | $25.77 | 36,505.0000 | 0 | 47.98% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 33665 | $13.13 | 85,830.0000 | 0 | 64.54% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 51 | $0.00 | 51,253.0000 | 0 | 0.10% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 51 | $13.13 | 52,165.0000 | 0 | 0.10% | 0.00% |
| Jan. 26, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 15609 | $12.90 | 52,114.0000 | 0 | 42.76% | 0.00% |
| Jan. 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 9604 | $12.90 | 47,566.0000 | 0 | 25.30% | 0.00% |
| Jan. 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 16413 | $3.26 | 63,979.0000 | 0 | 34.51% | 0.00% |
| Jan. 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 16413 | $25.45 | 47,566.0000 | 0 | 25.65% | 0.00% |
| Jan. 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 9604 | $25.27 | 37,962.0000 | 0 | 20.19% | 0.00% |
| Jan. 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 9604 | $0.00 | 8,721.0000 | 0 | 52.41% | 0.00% |
| Jan. 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 16413 | $0.00 | 68,742.0000 | 0 | 19.27% | 0.00% |
| Jan. 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 300 | $13.13 | 36,805.0000 | 0 | 0.82% | 0.00% |
| Jan. 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 300 | $12.90 | 37,105.0000 | 0 | 0.82% | 0.00% |
| Jan. 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 300 | $25.00 | 36,805.0000 | 0 | 0.81% | 0.00% |
| Jan. 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 300 | $25.00 | 36,505.0000 | 0 | 0.82% | 0.00% |
| Jan. 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 300 | $0.00 | 51,304.0000 | 0 | 0.58% | 0.00% |
| Jan. 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 300 | $0.00 | 16,635.0000 | 0 | 1.77% | 0.00% |
| Jan. 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 5600 | $25.01 | 37,962.0000 | 0 | 12.86% | 0.00% |
| Jan. 25, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 300 | $12.90 | 38,262.0000 | 0 | 0.79% | 0.00% |
| Jan. 25, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 300 | $3.26 | 38,562.0000 | 0 | 0.78% | 0.00% |
| Jan. 25, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 300 | $25.00 | 38,262.0000 | 0 | 0.78% | 0.00% |
| Jan. 25, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 300 | $25.00 | 37,962.0000 | 0 | 0.78% | 0.00% |
| Jan. 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 5600 | $0.00 | 18,625.0000 | 0 | 23.12% | 0.00% |
| Jan. 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 5700 | $0.00 | 85,455.0000 | 0 | 6.25% | 0.00% |
| Jan. 25, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 300 | $0.00 | 18,325.0000 | 0 | 1.61% | 0.00% |
| Jan. 25, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 300 | $0.00 | 85,155.0000 | 0 | 0.35% | 0.00% |
| Jan. 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 5600 | $12.90 | 43,562.0000 | 0 | 14.75% | 0.00% |
| Jan. 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 5700 | $3.26 | 49,262.0000 | 0 | 13.08% | 0.00% |
| Jan. 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 5700 | $25.01 | 43,562.0000 | 0 | 11.57% | 0.00% |
| Jan. 24, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 5651 | $0.00 | 16,935.0000 | 0 | 25.02% | 0.00% |
| Jan. 23, 2024 | Lurker Nancy | Executive Vice Chair | S | Common Stock | 5044 | $24.97 | 217,605.0000 | 0 | 2.27% | 0.00% |
| Jan. 24, 2024 | Lurker Nancy | Executive Vice Chair | S | Common Stock | 29956 | $24.98 | 187,649.0000 | 0 | 13.77% | 0.00% |
| Jan. 24, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 112700 | $0.00 | 450,800.0000 | 0 | 33.33% | 0.00% |
| Jan. 24, 2024 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 112700 | $0.00 | 450,800.0000 | 0 | 20.00% | 0.00% |
| Jan. 23, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 3096 | $13.13 | 39,601.0000 | 0 | 8.48% | 0.00% |
| Jan. 23, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 2039 | $12.90 | 41,640.0000 | 0 | 5.15% | 0.00% |
| Jan. 23, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 2039 | $25.00 | 39,601.0000 | 0 | 4.90% | 0.00% |
| Jan. 23, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 3096 | $25.00 | 36,505.0000 | 0 | 7.82% | 0.00% |
| Jan. 24, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 5651 | $12.90 | 42,156.0000 | 0 | 15.48% | 0.00% |
| Jan. 24, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 5600 | $13.13 | 47,756.0000 | 0 | 13.28% | 0.00% |
| Jan. 24, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 5600 | $25.01 | 42,156.0000 | 0 | 11.73% | 0.00% |
| Jan. 24, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 5651 | $25.02 | 36,505.0000 | 0 | 13.40% | 0.00% |
| Jan. 23, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 3096 | $0.00 | 57,204.0000 | 0 | 5.13% | 0.00% |
| Jan. 23, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 2039 | $0.00 | 22,586.0000 | 0 | 8.28% | 0.00% |
| Jan. 24, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 5600 | $0.00 | 51,604.0000 | 0 | 9.79% | 0.00% |
| Jan. 23, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 400 | $0.00 | 24,225.0000 | 0 | 1.62% | 0.00% |
| Jan. 23, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 500 | $0.00 | 91,155.0000 | 0 | 0.55% | 0.00% |
| Jan. 22, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 28750 | $0.00 | 31,250.0000 | 0 | 47.92% | 0.00% |
| Jan. 22, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Stock Option (Right to Buy) | 5416 | $0.00 | 4,584.0000 | 0 | 54.16% | 0.00% |
| Jan. 23, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 500 | $25.00 | 37,962.0000 | 0 | 1.30% | 0.00% |
| Jan. 23, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 400 | $25.00 | 38,462.0000 | 0 | 1.03% | 0.00% |
| Jan. 23, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 500 | $3.26 | 38,862.0000 | 0 | 1.30% | 0.00% |
| Jan. 23, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 400 | $12.90 | 38,362.0000 | 0 | 1.05% | 0.00% |
| Jan. 22, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 28750 | $22.69 | 37,962.0000 | 0 | 43.10% | 0.00% |
| Jan. 22, 2024 | Jones David Scott | SVP & Chief Commercial Officer | S | Common Stock | 5416 | $22.24 | 66,712.0000 | 0 | 7.51% | 0.00% |
| Jan. 22, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 5416 | $11.47 | 72,128.0000 | 0 | 8.12% | 0.00% |
| Jan. 22, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 28750 | $10.13 | 66,712.0000 | 0 | 75.73% | 0.00% |
| Jan. 11, 2024 | Ocumension Therapeutics | Director | S | common stock | 1910500 | $19.45 | 100,221.0000 | 0 | 95.02% | 0.00% |
| Jan. 11, 2024 | Liu Ye | Not found | S | Common Stock, $0.001 par value | 1910500 | $19.45 | 100,221.0000 | 0 | 95.02% | 0.00% |
| Jan. 11, 2024 | Cormorant Asset Management, LP | Not found | P | Common Stock | 750000 | $19.75 | 6,893,235.0000 | 0 | 12.21% | 0.00% |
| Jan. 9, 2024 | Cormorant Asset Management, LP | Not found | P | Common Stock | 105000 | $21.32 | 6,143,235.0000 | 0 | 1.74% | 0.00% |
| Jan. 8, 2024 | Paggiarino Dario A. | Chief Medical Officer | S | Common Stock | 22913 | $21.13 | 36,505.0000 | 0 | 38.56% | 0.00% |
| Jan. 8, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Stock Option (Right to Buy) | 22913 | $0.00 | 68,742.0000 | 0 | 25.00% | 0.00% |
| Jan. 8, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 22913 | $3.26 | 59,418.0000 | 0 | 62.77% | 0.00% |
| Jan. 5, 2024 | Paggiarino Dario A. | Chief Medical Officer | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Common Stock | 15285 | $0.00 | 40,992.0000 | 0 | 59.46% | 0.00% |
| Jan. 6, 2024 | Duker Jay S. | President and CEO | M | Common Stock | 20793 | $0.00 | 50,014.0000 | 0 | 71.16% | 0.00% |
| Jan. 6, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Restricted Stock Units | 15285 | $0.00 | 30,570.0000 | 0 | 33.33% | 0.00% |
| Jan. 5, 2024 | Jones David Scott | SVP & Chief Commercial Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | F | Common Stock | 5966 | $20.40 | 13,662.0000 | 0 | 30.40% | 0.00% |
| Jan. 6, 2024 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | M | Common Stock | 15285 | $0.00 | 19,628.0000 | 0 | 351.95% | 0.00% |
| Jan. 5, 2024 | Zaderej Karen L. | Not found | A | Stock Option (Right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Lurker Nancy | Executive Vice Chair | M | Restricted Stock Units | 75133 | $0.00 | 150,267.0000 | 0 | 33.33% | 0.00% |
| Jan. 5, 2024 | Lurker Nancy | Executive Vice Chair | A | Stock Option (Right to Buy) | 77000 | $0.00 | 77,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Lurker Nancy | Executive Vice Chair | A | Restricted Stock Units | 38000 | $0.00 | 38,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Lurker Nancy | Executive Vice Chair | F | Common Stock | 23043 | $20.40 | 170,441.0000 | 0 | 11.91% | 0.00% |
| Jan. 6, 2024 | Lurker Nancy | Executive Vice Chair | M | Common Stock | 75133 | $0.00 | 193,484.0000 | 0 | 63.48% | 0.00% |
| Jan. 6, 2024 | Paggiarino Dario A. | Chief Medical Officer | M | Restricted Stock Units | 15285 | $0.00 | 30,570.0000 | 0 | 33.33% | 0.00% |
| Jan. 5, 2024 | Paggiarino Dario A. | Chief Medical Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Paggiarino Dario A. | Chief Medical Officer | F | Common Stock | 4487 | $20.40 | 36,505.0000 | 0 | 10.95% | 0.00% |
| Jan. 5, 2024 | Jones David Scott | SVP & Chief Commercial Officer | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | M | Restricted Stock Units | 15285 | $0.00 | 30,570.0000 | 0 | 33.33% | 0.00% |
| Jan. 6, 2024 | Jones David Scott | SVP & Chief Commercial Officer | M | Common Stock | 15285 | $0.00 | 42,109.0000 | 0 | 56.98% | 0.00% |
| Jan. 6, 2024 | Jones David Scott | SVP & Chief Commercial Officer | F | Common Stock | 4147 | $20.40 | 37,962.0000 | 0 | 9.85% | 0.00% |
| Jan. 5, 2024 | ADAMIS ANTHONY P | Not found | A | Stock Option (Right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | ANDO GORAN | Not found | A | Stock Option (Right to Buy) | 23598 | $0.00 | 23,598.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | DICICCO WENDY F | Not found | A | Stock Option (Right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Duty Stuart | Not found | A | Stock Option (Right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Landis John B. | Not found | A | Stock Option (Right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Landis John B. | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Landis John B. | Not found | A | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | GUYER DAVID R | Not found | A | Stock Option (Right to Buy) | 25014 | $0.00 | 25,014.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Elston George | Chief Financial Officer | M | Restricted Stock Units | 15285 | $0.00 | 30,570.0000 | 0 | 33.33% | 0.00% |
| Jan. 5, 2024 | Elston George | Chief Financial Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Elston George | Chief Financial Officer | A | Restricted Stock Units | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Elston George | Chief Financial Officer | F | Common Stock | 4911 | $20.40 | 35,308.0000 | 0 | 12.21% | 0.00% |
| Jan. 6, 2024 | Elston George | Chief Financial Officer | M | Common Stock | 15285 | $0.00 | 40,219.0000 | 0 | 61.30% | 0.00% |
| Jan. 6, 2024 | Duker Jay S. | President and CEO | M | Restricted Stock Units | 20793 | $0.00 | 41,587.0000 | 0 | 33.33% | 0.00% |
| Jan. 5, 2024 | Duker Jay S. | President and CEO | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Duker Jay S. | President and CEO | A | Restricted Stock Units | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2024 | Duker Jay S. | President and CEO | F | Common Stock | 6528 | $20.40 | 43,486.0000 | 0 | 13.05% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Common Stock | 52208 | $0.00 | 170,559.0000 | 0 | 23.44% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 35000 | $0.00 | 240,000.0000 | 0 | 17.07% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Common Stock | 52208 | $0.00 | 170,559.0000 | 0 | 44.11% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 31164 | $0.00 | 172,330.0000 | 0 | 15.31% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 31164 | $0.00 | 281,370.0000 | 0 | 12.46% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 10906 | $0.00 | 114,674.0000 | 0 | 8.68% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 35000 | $0.00 | 240,000.0000 | 0 | 12.73% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 10906 | $0.00 | 200,126.0000 | 0 | 5.76% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 10906 | $0.00 | 114,674.0000 | 0 | 8.68% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 10906 | $0.00 | 200,126.0000 | 0 | 5.76% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 35000 | $0.00 | 240,000.0000 | 0 | 12.73% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 35000 | $0.00 | 240,000.0000 | 0 | 17.07% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 31164 | $0.00 | 172,330.0000 | 0 | 15.31% | 0.00% |
| Dec. 28, 2023 | Lurker Nancy | Executive Vice Chair | G | Stock Option (Right to Buy) | 31164 | $0.00 | 281,370.0000 | 0 | 12.46% | 0.00% |